The fact that multiple Danaher Corporation ( NYSE:DHR ) insiders offloaded a considerable amount of shares over ...

Danaher Corporation (NYSE:DHR) is a stock that Jim Cramer has a bittersweet relationship with. His trust has continued to ...

Danaher Corporation’s DHR second-quarter 2025 adjusted earnings of $1.80 per share beat the Zacks Consensus Estimate of $1.64. The bottom line increased 4.7% year over year. Danaher reported net sales ...

Danaher Corporation thrives on bioprocessing demand and diagnostics resilience. Click for why, with solid execution and 80% ...

Q2 2025 Earnings Call Transcript July 22, 2025 Danaher Corporation beats earnings expectations. Reported EPS is $1.8, ...

Danaher Corporation (NYSE:DHR) shareholders are probably feeling a little disappointed, since its shares fell 9.2% to US$223 in the week after its latest annual results.

--Danaher Corporation announced today that it has completed the separation of its Environmental& Applied Solutions segment, through the spin-off of Veralto Corporation. Veralto will begin "regular ...

Summary Danaher Corporation incorporates science and technology and has a market cap of $150B. The company has mixed financials, with its gross profit margin being its strongest and most consistent.

Danaher Corporation (NYSE:DHR) last week reported its latest full-year results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations ...

About a year ago, Danaher Corporation 's (NYSE: DHR) valuation looked cheap relative to its peers. Of course, when I write peers, I mean its medical, life sciences, and diagnostics peers because ...

Danaher's third quarter Compared to last year's third quarter, overall revenue increased 6.5%, comprising core revenue growth of 3% and contributions from acquisitions of 10.5%.